Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Catheter Precision (VTAK) Income towards Parent Company (2017 - 2025)

Catheter Precision has reported Income towards Parent Company over the past 9 years, most recently at -$7.7 million for Q4 2025.

  • Quarterly Income towards Parent Company fell 207.92% to -$7.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$21.1 million through Dec 2025, down 56.28% year-over-year, with the annual reading at -$19.5 million for FY2025, 44.46% down from the prior year.
  • Income towards Parent Company was -$7.7 million for Q4 2025 at Catheter Precision, down from -$2.3 million in the prior quarter.
  • Over five years, Income towards Parent Company peaked at $3.1 million in Q3 2021 and troughed at -$66.4 million in Q1 2023.
  • The 5-year median for Income towards Parent Company is -$4.2 million (2024), against an average of -$7.1 million.
  • Year-over-year, Income towards Parent Company soared 1266.67% in 2021 and then tumbled 1430.64% in 2022.
  • A 5-year view of Income towards Parent Company shows it stood at $3.1 million in 2021, then crashed by 364.9% to -$8.2 million in 2022, then surged by 91.8% to -$669000.0 in 2023, then crashed by 271.75% to -$2.5 million in 2024, then crashed by 207.92% to -$7.7 million in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Income towards Parent Company are -$7.7 million (Q4 2025), -$2.3 million (Q3 2025), and -$6.4 million (Q2 2025).